Biokarpet Sa Stock Net Asset
| BIOKA Stock | EUR 1.83 0.01 0.55% |
Biokarpet SA fundamentals help investors to digest information that contributes to Biokarpet's financial success or failures. It also enables traders to predict the movement of Biokarpet Stock. The fundamental analysis module provides a way to measure Biokarpet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biokarpet stock.
Biokarpet |
Biokarpet SA Company Net Asset Analysis
Biokarpet's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Biokarpet SA has a Net Asset of 0.0. This indicator is about the same for the Industrial Goods average (which is currently at 0.0) sector and about the same as Textile Industrial (which currently averages 0.0) industry. This indicator is about the same for all Greece stocks average (which is currently at 0.0).
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Biokarpet Fundamentals
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0474 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 125.55 M | |||
| Shares Outstanding | 23.99 M | |||
| Shares Owned By Insiders | 71.43 % | |||
| Shares Owned By Institutions | 5.17 % | |||
| Price To Earning | 118.57 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 228.71 M | |||
| Gross Profit | 31.48 M | |||
| EBITDA | 17.51 M | |||
| Net Income | 4.21 M | |||
| Cash And Equivalents | 3.13 M | |||
| Cash Per Share | 0.13 X | |||
| Total Debt | 74.45 M | |||
| Debt To Equity | 260.50 % | |||
| Current Ratio | 1.85 X | |||
| Book Value Per Share | 1.69 X | |||
| Cash Flow From Operations | 8.75 M | |||
| Earnings Per Share | 0.01 X | |||
| Beta | 0.75 | |||
| Market Capitalization | 43.66 M | |||
| Total Asset | 128 M | |||
| Retained Earnings | (37 M) | |||
| Working Capital | 25 M | |||
| Current Asset | 61 M | |||
| Current Liabilities | 36 M | |||
| Z Score | 1.0 | |||
| Five Year Return | 1.91 % |
About Biokarpet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biokarpet SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biokarpet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biokarpet SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biokarpet Stock
Biokarpet financial ratios help investors to determine whether Biokarpet Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biokarpet with respect to the benefits of owning Biokarpet security.